4th Quarter - Report

SMITH & NEPHEW, INC. for SMITH & NEPHEW, INC.

Period 4th Quarter 2013 Filed Jan 21, 2014 Signed by Paul A. Seltman, Senior Vice President, Government Affairs & Reimbursement

Official filing
Firm
SMITH & NEPHEW, INC.
Client
SMITH & NEPHEW, INC.
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist., HHS; Counsel, Sen. Budget Com.
TODD SPANGLER House Ed & Workforce Cte; Senate HELP Cte

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2725 (113th), S. 1413 (113th)

Government Issues GOV

Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).

Foreign entity interest: This legislation focuses on promoting foreign direct investment in the United States and identifying barriers to such investment. Smith & Nephew, Inc.'s parent company Smith & Nephew plc is a British company with an interest in continuing to invest in the United States.

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist, HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: H.R. 2052 (113th), S. 1023 (113th)

Taxation/Internal Revenue Code TAX

Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist., HHS; Counsel, Sen. Budget Com.
TODD SPANGLER House Ed & Workforce Cte; Senate HELP Cte

Contacted: Natl Economic Council (NEC); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 523 (113th), S. 232 (113th)

Medicare/Medicaid MMM

Durable Medical Equipment (DME) provisions in the Medicare proposed rule for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (CMS-1526-P), published on July 8, 2013. Medicare Drug Savings Act (H.R. 1588, S. 740).Provisions related to packaging of drugs and biologicals in the Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system (CMS-1601-P), published on July 8, 2013. SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871).

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist, HHS; Counsel, Sen. Budget Com.
TODD SPANGLER House Ed & Workforce Cte; Senate HELP Cte

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS)

Bills named: S. 740 (113th), S. 1871 (113th), H.R. 1588 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.